• Albisetti M, Ardila J, Astermark J, Blatny J, Carcao M, Chowdary P, Connell NT, Crato M, Dargaud Y, d’Oiron R, Dunn AL, Escobar MA, Ettingshausen CE, Fischer K, Gouider E, Harroche A, Hermans C, Jimenez-Yuste V, Kaczmarek R, Kenet G, Khoo L, Klamroth R, Langer F, Lillicrap D, Mahlangu J, Male C, Mancuso ME, Matsushita T, Meunier S, Miesbach W, Nolan B, Oldenburg J, O’Mahony B, Ozelo M, Pierce GF, Ramos G, Recht M, Romero-Lux O, Rotellini D, Santoro RC, Singleton TC, Skinner MW, Srivastava A, Susen S, Talks K, Tran H, Valentino LA, Windyga J, Yang R; also on behalf of AICE, AHAD‐AP, AHCDC, ATHN, CLAHT, EHC, French CRH & MHEMO, GTH, HTCCNC, NBDF, PEDNET, UKHCDO, WFH. International Society on Thrombosis and Haemostasis Clinical Practice Guideline for Treatment of Congenital Haemophilia-A Critical Appraisal. Haemophilia. 2024 Dec 6.doi: 10.1111/hae.15135

• Andersson NG, De Kovel M, Castaman G, D’Oiron R, Kenet G, Konigs C, Male C, Nolan B, Olivieri M, Pinto F, Sigurgisladottir S, Zapotocka E, Fischer K. Intracranial hemorrhage before start of prophylaxis in children with hemophilia: incidence, timing, and potential for prevention. Haematologica 2025 Apr 1;110(4):914-922.

• Angénieux C, Nipoti T, Rojas-Jiménez G, Daniel M, Adam F, Dupont A, Maître B, Kauskot A. Unveiling platelet aging with progressive β-galactose exposure as a signature of platelet senescence in humans and mice. Haematologica. 2025 Jul 3.

• Auditeau C, Nguyen TS, Devaux F, Saller F, Peyron I, Blandinieres A, Reperant C, Darame S, Denis C, Lenting PJ, Borgel D, Bianchini EP. An inhibitory single-domain antibody against protein Z-dependent protease inhibitor promotes thrombin generation in hemophilia A and FXI deficiency. Thromb Haemost. 2025 Mar;125(3):207-217.

• Auditeau C, Valsecchi C, Bentounes NK, Le-Goff A, Harroche A, Bally C, Lenting PJ, Borgel D, Peyvandi F, Lasne D. Implementing an assay detecting anti-drug antibody against emicizumab: experience from one center in France. Thromb Haemost. 2025

• Avoine J, Harroche A, Azarnoush S, Huguenin Y, Blandinieres A, De Raucourt E, Galeotti C, Theron A. Acquired factor XI deficiency in paediatrics patients: A French series and review of literature cases. Thromb Res. 2025 Mar;247:109282.

• Billeret M, Blandinières A, Touati D, Desconclois C, Garreau R, Le Gouez A, Lavenu-Bombled C, Bruyère M. Moderate factor XI deficiency and neuraxial procedures in an obstetric cohort: a retrospective study (2014-2021). Int J Obstet Anesth. 2025 Feb;61:104289.

• Blandinières A, Combe S, Chanson N, Lambotte O, Lavenu-Bombled C. Use of Vonicog Alpha and Acquired von Willebrand Syndrome, a New Approach: A Case Report. 2025, In press

• Bogey C, Rouchaud A, Gentric JC, Beaufreton E, Timsit S, Clarencon F, Caroff J, Bourcier R, Zhu F, Dargazanli C, Hak JF, Boulouis G, Ifergan H, Pop R, Forestier G, Lapergue B, Ognard J; Etis Investigators. Predictive models of clinical outcome of endovascular treatment for anterior circulation stroke using machine learning. J Neurosci Methods. 2025 Apr;416:110376.

• Burel J, Agripnidis T, Rouchaud A, Marnat G, Caroff J, Zhu F, Kerleroux B, Berge J, Pruvo JP, Desal H, Boulouis G; SFNR Board. Interventional neuroradiology in France in 2025: Scaling up expertise, access, and innovation. J Neuroradiol. 2025 May 14;52(4):101350.

• Cortese J, Juhasz J, Rodriguez-Erazú F, Ghozy S, Bayraktar EA, Mihalea C, Zarrintan A, Ueki Y, Caroff J, Kallmes DF, Spelle L, Kadirvel R. Neck apposition is a key factor for aneurysm occlusion after Woven EndoBridge device embolization. J Neurointerv Surg. 2025

• Deliktas Y, Derraz I, Finitsis S, Caroff J, Bourcier R, Soize S, Moulin S, Richard S, Marnat G, Hoferica M, Cognard C, Desilles JP, Anadani M, Olivot JM, Casolla B, Consoli A, Lapergue B, Gory B; ETIS Registry Investigators. Clinical and safety outcomes of acute stenting plus thrombectomy for carotid tandem lesions with large ischemic core. J Neurointerv Surg. 2025

• Devauchelle P, Bignon A, Breteau I, Defaye M, Degravi L, Despres C, Godon A, Guérin R, Lavayssiere L, Lebas B, Maurice A, Monet C, Monsel A, Reydellet L, Roullet S, Rozier R, Guichon C, Weiss E; for the French Special Interest Group “Liver Anesthesiology and Intensive Care”. Perioperative Management During Liver Transplantation: A National Survey From the French Special Interest Group in « Liver Anesthesiology and Intensive Care ». 2025 Apr 1;109(4):671-680.

• Dolan G, Fijnvandraat K, Lenting PJ, Catarino C, Lavin M; Factor Think Tank. Nonsevere Hemophilia: The Need for a Renewed Focus and Improved Outcomes. Semin Thromb Hemost. 2025 Feb;51(1):58-67.

• Doubre H, Pascreau T, Vasse M. Validation of clinical risk assessment scores for venous thromboembolism in patients with cancer: a population-based cohort study: comment from Doubre et al. J Thromb Haemost. 2025 Jun;23(6):2069-2070.

• Dubois MD, Pierre-Louis ON, Pierre-Louis S, Boisseau P, Denis CV, Dupont A, Goudemand J, Casari C, Jeanpierre E, Zawadzki C, Ferrey B, Rabout J, Fuseau P, Chonville E, Michel F, Yerro MN, Gruel Y, Christophe O, Lenting PJ, Janky E, Susen S, Neviere R. Clinical, Phenotypic and Genotypic Characteristics of Von Willebrand Disease in Afro-Caribbeans: Results From a Study in Martinique Island, French West Indies. 2025

• El Hamaoui D, Marchelli A, Gandrille S, Reboul E, Stepanian A, Palmier B, Jovine L, Lebrin F, Smadja DM, Bernabeu C, Denis CV, Gaussem P, Pasquali S, Kauskot A, Rossi E. Thrombin cleaves membrane-bound endoglin potentially contributing to the heterogeneity of circulating endoglin in preeclampsia. Commun Biol. 2025 Feb 26;8(1):316.

• Gilbert F, Consoli A, Lavallee P, Caroff J, Mazighi M, Marnat G, Arquiza C, Ferre JC, Viguier A, Kyheng M, Weisenburger D, Lapergue B; ETIS investigators. Door-to-puncture time in ischemic stroke with large vessel occlusion in France: Patient and hospital factors. Rev Neurol (Paris). 2025

• Gouin-Thibault I, Lecompte T, Lasne D. Anticoagulant drugs targeting Factor XI/XIa and coagulation tests: we urgently need reliable pharmacodynamic data. J Thromb Haemost. 2025 May;23(5):1464-1468.

• Ifergan H, Dargazanli C, Hassen WB, Hak JF, Gory B, Ognard J, Premat K, Marnat G, Kerleroux B, Zhu F, Bellanger G, Sporns PB, Charbonnier G, Forestier G, Caroff J, Fauché C, Clarençon F, Janot K, Lapergue B, Boulouis G; ETIS registry collaborators and the JENI research collaborative. Determinants of day-1 stent patency following rescue intracranial stenting in failed intracranial thrombectomy. Interv Neuroradiol. 2025

• Kartal-Kaess M, Pinto F, Labarque V, de Kovel M, Nolan B, Carcao M, d’Oiron R, Stamm Mikkelsen T, Ljung R, Andersson NG; PedNet Study Group. Hemophilia B Leyden: Characteristics and natural history in the PedgNet Registry. J Thromb Haemost. 2025 Mar;23(3):921-927.

• Kauskot A, Ramstrom S, Nipoti T, van der Wal DE. Consensus protocol for platelet desialylation (β-galactose exposure) quantification using lectins by flow cytometry: communication from the ISTH SSC Subcommittee on Platelet Physiology. J Thromb Haemost. 2025 Jun;23(6):2050-2059.

• Khourssaji M, Bareille M, Alberio L, Borgel D, Fouassier M, Bene MC, Lecompte T, Mullier F. Mepacrine flow cytometry assay for the diagnosis of platelet δ-granule defects : literature review on methods – towards a shared detailed protocol. Thromb Haemost. 2025

• Linthorst NA, Jongejan YK, Dirven RJ, Laan SNJ, Bierings R, Casari C, Cordfunke RA, Dahlman JE, Dolezal N, Drijfhout JW, Leebeek FWG, Ruhaak LR, Echeverri LS, Voorberg J, van Vlijmen BJM, Denis CV, Eikenboom JCJ. Amelioration of a von Willebrand disease type 2B phenotype in vivo upon treatment with allele-selective siRNAs. Blood Adv. 2025 Jan 28;9(2):310-320.

• Lordier L, Di Buduo CA, Kauskot A, Balayn N, Lavenu-Bombled C, Baschieri F, Proulle V, Oyarzun CPM, Careddu F, Biunno I, Manoliu T, Rameau P, Plo I, Papadopoulos N, Constantinescu S, Vainchenker W, Nguyen GN, Ballerini P, Favier R, Balduini A, Raslova H. Increased RhoA pathway activation downstream of αIIbβ3/SRC contributes to heterozygous Bernard Soulier syndrome. Haematologica. 2025 Mar 6.

• McCluskey G*, Heestermans M*, Peyron I, Pascal E, Clavel M, Bun E, Bocquet E, Reperant C, Susen S, Christophe O, Denis CV, Lenting PJ*, Casari C*. A fully humanized von Willebrand disease-type 1 mouse model as unique platform to investigate novel therapeutic options. Haematologica, 2025 Apr 1;110(4):923-937. * Co-first and co-last authors.

• Milnerowicz M, Desilles JP, Pop R, Dargazanli C, Labreuche J, Sibon I, Gory B, Soize S, Bourcier R, Mazighi M, Cognard C, Caroff J, Gentric JC, Clarençon F, Richter S, Janot K, Lapergue B, Marnat G; ETIS investigators. Cangrelor versus GPIIb/IIIa inhibitors as adjunctive therapy in endovascular treatment of large vessel occlusion stroke. J Neurointerv Surg. 2025

• Perrier-Cornet A, Gendron N, Desconclois C, Planche V, Vayne C, Gac FN, Lavenu-Bombled C, Lasne D, Flaujac C, Hormi M. [Overview of practices among French clinical pathologists specialized in haemostasis]. Ann Biol Clin (Paris). 2025 May 22;83(2):147-60.

• Pop R, Finitsis SN, Marnat G, Derraz I, Cognard C, Calviere L, Caroff J, Clarençon F, Delvoye F, Consoli A, Lapergue B, Gory B; ETIS Registry Investigators. Cangrelor for emergent carotid stenting during stroke thrombectomy: a comparative analysis versus glycoprotein IIb/IIIa inhibitors or aspirin monotherapy. J Neurointerv Surg. 2025 Jun 1;17(e2):e269-e275.

• Popica DA, Cortese J, Oliver AA, Plaforet V, Molina Diaz I, Rodriguez-Erazú F, Ikka L, Mihalea C, Chalumeau V, Kallmes DF, Caroff J, Spelle L. Flow diverter braid deformation following treatment of cerebral aneurysms: incidence, clinical relevance, and potential risk factors. J Neurointerv Surg. 2025

• Reyes-Ruiz A, Delignat S, Bhale AS, Daventure V, Lacombe RV, Dourthe L, Christophe O, Justesen S, Venkataraman K, Dimitrov JD, Lacroix-Desmazes S. Binding of therapeutic Fc-fused factor VIII to the neonatal Fc receptor at neutral pH associates with poor half-life extension. Haematologica

• Sarov-Riviere M, Ancelet C, Nasser G, Caroff J, Aghakhani N, Denier C. Trigeminal Neuralgia as a Rare Complication of Idiopathic Intracranial Hypertension. Case Rep Neurol. 2025 Apr 7;17(1):57-61.

• Saultier P, Grino M, Falaise C, Voisin S, Lavenu-Bombled C, Ibrahim-Kosta M, Petit A, Boutroux H, Desprez D, Fiore M, d’Oiron R, Alessi MC. Efficacy and safety of recombinant activated factor VII in Glanzmann thrombasthenia: A systematic literature review. Haemophilia. 2025 Jan;31(1):7-15.

• Sefiane T, McCluskey G, Clavel M, Maynadié H, Peyron I, Tovo D, Brochier C, Saller F, Khamari M, Denis CV, Christophe OD, Lenting PJ, Muxczynski V*, Casari C*. A consistent clinical factor VIII-equivalence is unlikely to exist for non-factor therapies in hemophilic mice. Haematologica.

• Solarz J, Soukaseum C, Frémont S, Eymieux S, Nabli C, Repérant C, Rossi E, Bordet JC, Denis CV, Mangin P, Boulaftali Y, Pasterkamp RJ, Raslova H, Baruch D, Adam F, Echard A, Kauskot A. F-actin disassembly by the oxidoreductase MICAL1 promotes mechano-dependent VWF-GPIbα interaction in platelets. Nature communications, 2025 Aug 10;16(1):7375. doi: 10.1038/s41467-025-62487-2.

• Skinner MW, Albisetti M, Ardila J, Astermark J, Blatny J, Carcao M, Chowdary P, Connell NT, Crato M, Dargaud Y, d’Oiron R, Dunn AL, Escobar MA, Escuriola-Ettingshausen C, Gouider E, Harroche A, Hermans C, Jimenez-Yuste V, Kaczmarek R, Kenet G, Khoo L, Klamroth R, Langer F, Lillicrap D, Mahlangu J, Male C, Matsushita T, Meunier S, Miesbach W, Nolan B, Oldenburg J, O’Mahony B, Ozelo M, Pierce GF, Ramos G, Recht M, Romero-Lux O, Rotellini D, Santoro RC, Singleton TC, Srivastava A, Susen S, Talks K, Tran H, Valentino LA, Windyga J, Yang R, Mancuso ME; also on behalf of AICEAHAD‐APAHCDCATHNCLAHTEHCFrench CRH & MHEMOHTCCNCNBDFPEDNETUKHCDOWFH. Contrasting Approaches in the Implementation of GRADE Methodology in Guidelines for Haemophilia and Von Willebrand Disease.

• Spelle L, Costalat V, Caroff J, Wodarg F, Fischer S, Herbreteau D, Möhlenbruch MA, Januel AC, Papagiannaki C, Klisch J, Numminen J, Rautio R, Berlis A, Mihalea C, Chalumeau V, Downer J, Cortese J, Ikka L, Gallas S, Bester M, Liebig T, Velasco S, Grimaldi L, Byrne J, Szikora I, Pierot L, Cognard C. CLinical EValuation of WEB 17 device in intracranial aneuRysms (CLEVER): 1-year effectiveness results for ruptured and unruptured aneurysms. J Neurointerv Surg. 2025

• Tournier L, Cortese J, Consoli A, Spelle L, Marnat G, Sarov M, Zhu F, Soize S, Burel J, Forestier G, Escalard S, Pop R, Bonnet B, Alias Q, Ognard J, Naggara O, Kyheng M, Lapergue B, Caroff J; ETIS Registry Investigators. Mechanical thrombectomy in basilar artery occlusions: impact of first-line strategy as a function of the occlusion level. J Neurointerv Surg. 2025 Mar 17;17(4):346-353.

• Volot F, Castet S, Fournel A, Frotscher B, Gillet B, Desprez D, Tardy B, Rauch A, Chamouni P, Biron-Andreani C, Valentin JB, Harroche A, Dargaud Y, Petesch BP, d’Oiron R, Berger C, Reynes C, Lauvray T, de Raucourt E, Hassoun A, Lebreton A, Cussac V, Catovic H, Martin C, Guillet B. ORPHEE: A Real-World Study on rIX-FP Prophylaxis Use in Adolescent/Adult Patients With Hemophilia B. Eur J Haematol. 2025 Mar;114(3):508-516.

• Wheeler AP, Abraham A, Barnes C, Brown Frandsen R, d’Oiron R, Eichler H, Hampton K, López-Jaime FJ, Lyu CJ, Tavares CMM, Nogami K, Sutton C, Windyga J, Zulfikar B, Castaman G. Real-World Unmet Needs of Patients With Haemophilia A and Haemophilia B With or Without Inhibitors: End-of-Study Results From the explorer6 Non-Interventional Study.

• Yger M, Januel E, Checkouri T, Chausson N, Smadja D, Caroff J, Olindo S, Marnat G, Wiener E, Pico F, Turc G, Ben Hassen W, Seners P, Piotin M, Clarençon F, Alamowitch S, Gerschenfeld G. Sex differences in outcomes and time to treatment in stroke patients treated with tenecteplase. Eur Stroke J. 2025